microRNAs Derived from Circulating Exosomes as Noninvasive Biomarkers for Screening and Diagnosing Lung Cancer

Siegel, 2011, Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths, CA Cancer J Clin, 61, 212, 10.3322/caac.20121

The National Lung Screening Trial Research Team, 2011, Reduced lung-cancer mortality with low-dose computed tomographic screening, N Engl J Med, 365, 395, 10.1056/NEJMoa1102873

Zomer, 2010, Exosomes: fit to deliver small RNA, Commun Integr Biol, 3, 447, 10.4161/cib.3.5.12339

Mitchell, 2008, Circulating microRNAs as stable blood-based markers for cancer detection, Proc Natl Acad Sci U S A, 105, 10513, 10.1073/pnas.0804549105

Cortez, 2009, MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases, Expert Opin Biol Ther, 9, 703, 10.1517/14712590902932889

Garzon, 2009, MicroRNAs in cancer, Annu Rev Med, 60, 167, 10.1146/annurev.med.59.053006.104707

Shen, 2011, Plasma microRNAs as potential biomarkers for non-small-cell lung cancer, Lab Invest, 91, 579, 10.1038/labinvest.2010.194

Lebanony, 2009, Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma, J Clin Oncol, 27, 2030, 10.1200/JCO.2008.19.4134

Boeri, 2011, MicroRNA signatures in tissues and plasma predict development and prognosis of CT detected lung cancer, Proc Natl Acad Sci USA, 108, 3713, 10.1073/pnas.1100048108

Zheng, 2011, Plasma microRNAs as novel biomarkers for early detection of lung cancer, Int J Clin Exp Pathol, 4, 575

Valadi, 2007, Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells, Nat Cell Biol, 9, 654, 10.1038/ncb1596

Chen, 2008, Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases, Cell Res, 18, 997, 10.1038/cr.2008.282

Yang, 2011, The roles of tumor-derived exosomes in cancer pathogenesis, Clin Dev Immunol, 2011, 842849, 10.1155/2011/842849

Juan, 2011, Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer, Chin J Cancer, 30, 407, 10.5732/cjc.010.10522

Jensen, 2004, Normalization of real-time quantitative RT-PCR data: a model based variance estimation approach to identify genes suited for normalization—applied to bladder- and colon-cancer data-sets, Cancer Research, 5245

Witten, 2005

Lodes, 2009, Detection of cancer with Serum microRNAs on an Oligonucleotide Microarray, PLoS One, 4, e6229, 10.1371/journal.pone.0006229

National Cancer Institute. Statistical tools and data (Cancer.gov web site). May, 2011. Available at: http://www.cancer.gov/statistics. Accessed may 5, 2011

Heisey, 2011, Health care strategies to promote earlier presentation of symptomatic breast cancer: perspectives of women and family physicians, Curr Oncol, 18, e227, 10.3747/co.v18i5.869

Majek, 2011, Breast cancer screening in the Czech Republic: time trends in performance indicators during the first seven years of the organised programme, BMC Public Health, 11, 288, 10.1186/1471-2458-11-288

Arolfo, 2011, Gastrointestinal stromal tumors: thirty years experience of an institution, World J Gastroenterol, 17, 1836, 10.3748/wjg.v17.i14.1836

Rabinowits, 2009, Exosomal microRNA: a diagnostic marker for lung cancer, Clin Lung Cancer, 10, 42, 10.3816/CLC.2009.n.006

Bach, 2007, Computed tomography screening and lung cancer outcomes, JAMA, 297, 953, 10.1001/jama.297.9.953

Pastorino, 2010, Lung cancer screening, Br J Cancer, 102, 1681, 10.1038/sj.bjc.6605660

Davalos, 2010, MicroRNAs and cancer epigenetics: a macrorevolution, Curr Opin Oncol, 22, 35, 10.1097/CCO.0b013e328333dcbb

Patnaik, 2010, Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection, Cancer Res, 70, 36, 10.1158/0008-5472.CAN-09-3153

Navon, 2009, Novel rank-based statistical methods reveal microRNAs with differential expression in multiple cancer types, PLoS One, 4, e8003, 10.1371/journal.pone.0008003

Gao, 2011, MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis, J Cancer Res Clin Oncol, 137, 557, 10.1007/s00432-010-0918-4

Eichner, 2010, miR-378(*) mediates metabolic shift in breast cancer cells via the PGC-1β/ERRγ transcriptional pathway, Cell Metab, 12, 352, 10.1016/j.cmet.2010.09.002

Kumarswamy, 2012, MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer, Int J Cancer, 130, 2044, 10.1002/ijc.26218

Fridman, 2010, Accurate molecular classification of renal tumors using microRNA expression, J Mol Diagn, 12, 687, 10.2353/jmoldx.2010.090187

Chang, 2011, MicroRNA signature analysis in colorectal cancer: identification of expression profiles in stage II tumors associated with aggressive disease, Int J Colorectal Dis, 26, 1415, 10.1007/s00384-011-1279-4

Ding, 2010, Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA, Nat Cell Biol, 12, 390, 10.1038/ncb2039

Niemoeller, 2011, MicroRNA expression profiles in human cancer cells after ionizing radiation, Radiat Oncol, 6, 29, 10.1186/1748-717X-6-29

Wang, 2011, Human tumor microRNA signatures derived from large-scale oligonucleotide microarray datasets, Int J Cancer, 129, 1624, 10.1002/ijc.25818

Haenisch, 2011, Down-regulation of ATP-binding cassette C2 protein expression in HepG2 cells after rifampicin treatment is mediated by microRNA-379, Mol Pharmacol, 80, 314, 10.1124/mol.110.070714

Guo, 2010, Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis, Eur J Cancer, 46, 1692, 10.1016/j.ejca.2010.02.043